Case study

Generating publishable neuroscience research in 12 weeks with ioGlutamatergic Neurons

This case study showcases the research of Professor Deepak Srivastava's lab at King’s College London, and their use of cutting-edge human iPSC-derived cells to optimise their experimental timelines in their recent publication identifying schizophrenia risk factors.
Generating publishable neuroscience research in 12 weeks with ioGlutamatergic Neurons

Professor Deepak Srivastava

Professor of Molecular Neuroscience and Group Leader, MRC Centre for Developmental Disorders

King’s College London 

Generating publishable neuroscience research in 12 weeks with ioGlutamatergic Neurons
This case study showcases the research of Professor Deepak Srivastava's lab at King’s College London, and their use of cutting-edge human iPSC-derived cells to optimise their experimental timelines in their recent publication identifying schizophrenia risk factors.
Generating publishable neuroscience research in 12 weeks with ioGlutamatergic Neurons

Professor Deepak Srivastava

Professor of Molecular Neuroscience and Group Leader, MRC Centre for Developmental Disorders

King’s College London 

It took Professor Deepak Srivastava’s lab at King’s College London just 12 weeks to generate publishable data on schizophrenia risk factors. This dramatically short research timeline was driven by the lab’s push to maximise the value of their students’ time at the bench and was achieved by adopting precision reprogrammed human iPSC-derived glutamatergic neurons in their experiments.

In this case study, you will learn:

  • About Professor Srivastava’s research on the molecular mechanisms that impact cognitive function, and his focus on Schizophrenia.
  • How his lab use hiPSC-derived excitatory neurons to model key triggers that may impact an individual’s propensity to develop schizophrenia during their lifetime.
  • How the use of opti-ox powered human iPSC-derived cells has enabled his lab to optimise their time at the bench.

V2

2024

bit.bio

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell coding platform behind our cells
Join us Explore the latest roles at bit.bio